Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chandana Lakkaraju"'
Autor:
Chandana Lakkaraju
Publikováno v:
International Journal of Pure & Applied Bioscience. 6:196-201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53e66b5bc2771f9a4e1b16acbd221b84
https://doi.org/10.18782/2320-7051.6374
https://doi.org/10.18782/2320-7051.6374
Autor:
N. Pratibha Nallari, Amaresh Rao Malempati, Sailaja Maddhuri, Suresh Gudala, Chandana Lakkaraju, Hema Prasad Mundluru
Publikováno v:
Meta Gene. 15:16-22
Myocyte enhancer factor-2A (MEF2A), encoding a member of the MEF2 family of transcription factors, has been identified for primary CAD and MI without other accompanying clinical feature. It plays a role in vascular ontogeny and shows its predominant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecbf125bcd2cfcc3eda1650846331541
https://doi.org/10.1016/j.mgene.2017.10.001
https://doi.org/10.1016/j.mgene.2017.10.001
Autor:
Anuraj Nayarisseri, Arash Boroumand Nasr, Suresh Gudala, Ramesh Kumar Kattamuri, Chandana Lakkaraju, Deepika Ponnala, Someshwar Rao Sagurthi, Srinivas Bandaru, Vijaya Kumar Marri
Publikováno v:
Bioinformation
Mammalian target of rapamycin (mTOR) is a key regulator of cell growth, proliferation and angiogenesis. mTOR signaling is frequently hyper activated in a broad spectrum of human cancers thereby making it a potential drug target. The current drugs ava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f6b86d8d82e0846ba04757a005ff2c
http://europepmc.org/articles/PMC4512006
http://europepmc.org/articles/PMC4512006
Autor:
Anuraj Nayarisseri, Gutlapalli Vr, Kavisha Patidar, Amandeep Girdhar, Chandana Lakkaraju, Srinivas Bandaru, Tushar Banerjee, Aruna Deshmukh, Sanjeev Kumar Singh
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 17(4)
Small molecule tyrosine kinase inhibitors targeting HER 2 receptors have emerged as an important therapeutic approach in inhibition of downstream proliferation and survival signals for the treatment of breast cancers. Recent drug discovery efforts ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc3fb13350f1dfc06bab15a42085bc6
https://pubmed.ncbi.nlm.nih.gov/27221932
https://pubmed.ncbi.nlm.nih.gov/27221932
Autor:
Srinivas Bandaru, Uzma Shaheen, Anuraj Nayarisseri, Chandana Lakkaraju, Deepika Ponnala, Chaitanya Kumar Bhukya
Publikováno v:
Proceedings of MOL2NET, International Conference on Multidisciplinary Sciences.
Hub proteins in interaction networks involved in signaling pathways are known to have more disordered residues than non-hubs. Since the signaling mechanisms involving PPI are regulated by phosphorylation, disordered interfaces could be thought to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42cf604726a9751e4470baf6758b8f37
https://doi.org/10.3390/mol2net-1-b017
https://doi.org/10.3390/mol2net-1-b017
Autor:
Chandana Lakkaraju, Chaitanya Kumar Bhukya, Srinivas Bandaru, Uzma Shaheen, Deepika Ponnala, Anuraj Nayarisseri
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 16(9)
Background: Approaches in disruption of MDM2-p53 interactions have now emerged as an important therapeutic strategy in resurrecting wild type p53 functional status. The present study highlights virtual screening strategies in identification of high a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f47f16f06bc9d616eb72459651ff28e
https://pubmed.ncbi.nlm.nih.gov/25987034
https://pubmed.ncbi.nlm.nih.gov/25987034